OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 51 filers reported holding OVID THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $29,000 | -25.6% | 16,253 | 0.0% | 0.00% | – |
Q4 2018 | $39,000 | -78.8% | 16,253 | -50.0% | 0.00% | – |
Q3 2018 | $184,000 | +44.9% | 32,506 | +100.0% | 0.00% | – |
Q2 2018 | $127,000 | +111.7% | 16,253 | +168.1% | 0.00% | – |
Q4 2017 | $60,000 | +15.4% | 6,063 | 0.0% | 0.00% | – |
Q3 2017 | $52,000 | -18.8% | 6,063 | 0.0% | 0.00% | – |
Q2 2017 | $64,000 | – | 6,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |